Department of Medical Psychology, Center of Expertise on Gender Dysphoria, Amsterdam University Medical Centers, 1081 HX, Amsterdam, The Netherlands.
Department of Developmental and Educational Psychology, Brain and Development Research Center, Leiden University, Leiden, The Netherlands.
Arch Sex Behav. 2020 Feb;49(2):455-465. doi: 10.1007/s10508-020-01652-8. Epub 2020 Feb 13.
Click-evoked otoacoustic emissions (CEOAEs) are echo-like sounds, generated by the inner ear in response to click-stimuli. A sex difference in emission strength is observed in neonates and adults, with weaker CEOAE amplitudes in males. These differences are assumed to originate from testosterone influences during prenatal male sexual differentiation and to remain stable throughout life. However, recent studies suggested activational, postnatal effects of sex hormones on CEOAEs. Adolescents diagnosed with gender dysphoria (GD) may receive gonadotropin-releasing hormone analogs (GnRHa) in order to suppress endogenous sex hormones and, therefore, pubertal maturation, followed by cross-sex hormone (CSH) treatment. Using a cross-sectional design, we examined whether hormonal interventions in adolescents diagnosed with GD (62 trans boys, assigned female at birth, self-identifying as male; 43 trans girls, assigned male at birth, self-identifying as female), affected their CEOAEs compared to age- and sex-matched controls (44 boys, 37 girls). Sex-typical differences in CEOAE amplitude were observed among cisgender controls and treatment-naïve trans boys but not in other groups with GD. Treatment-naïve trans girls tended to have more female-typical CEOAEs, suggesting hypomasculinized early sexual differentiation, in support of a prominent hypothesis on the etiology of GD. In line with the predicted suppressive effects of androgens, trans boys receiving CSH treatment, i.e., testosterone plus GnRHa, showed significantly weaker right-ear CEOAEs compared with control girls. A similar trend was seen in trans boys treated with GnRHa only. Unexpectedly, trans girls showed CEOAE masculinization with addition of estradiol. Our findings show that CEOAEs may not be used as an unequivocal measure of prenatal androgen exposure as they can be modulated postnatally by sex hormones, in the form of hormonal treatment.
Click-evoked otoacoustic emissions (CEOAEs) 是一种类似回声的声音,由内耳对 click-stimuli 产生。在新生儿和成年人中观察到发射强度的性别差异,男性的 CEOAE 幅度较弱。这些差异被认为起源于男性性分化过程中的睾酮影响,并在整个生命周期中保持稳定。然而,最近的研究表明,性激素对 CEOAEs 有激活的、产后的影响。被诊断患有性别焦虑症 (GD) 的青少年可能会接受促性腺激素释放激素类似物 (GnRHa) 治疗,以抑制内源性性激素,从而抑制青春期成熟,随后进行跨性激素 (CSH) 治疗。使用横断面设计,我们研究了 GD 青少年(62 名跨性别男孩,出生时被分配为女性,自我认同为男性;43 名跨性别女孩,出生时被分配为男性,自我认同为女性)在接受激素干预后,与年龄和性别匹配的对照组(44 名男孩,37 名女孩)相比,他们的 CEOAEs 是否受到影响。在 cisgender 对照组和未经治疗的跨性别男孩中观察到 CEOAE 幅度的性别典型差异,但在其他 GD 组中没有观察到。未经治疗的跨性别女孩的 CEOAEs 往往更具女性典型性,这表明早期性分化的雄激素不足,支持 GD 病因的一个主要假说。与雄激素的预期抑制作用一致,接受 CSH 治疗的跨性别男孩,即睾酮加 GnRHa,与对照组女孩相比,右耳 CEOAE 明显较弱。仅接受 GnRHa 治疗的跨性别男孩也出现了类似的趋势。出乎意料的是,添加雌二醇后,跨性别女孩的 CEOAEs 出现了男性化。我们的研究结果表明,CEOAEs 不能作为产前雄激素暴露的明确指标,因为它们可以在产后通过性激素的形式,即激素治疗来调节。